Tracking cancer risk: national study follows patients with rare genetic condition

NCT ID NCT05630105

Recruiting now Knowledge-focused Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

Summary

This study aims to better understand how likely people with a specific genetic change (PTEN mutation) are to develop cancer. Researchers will follow 430 participants in France over time by collecting their medical history and sending annual health updates. The goal is to gather information to improve future care and screening recommendations for this group.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTEN GENE MUTATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Institut Bergonié, Comprehensive Cancer Center
RECRUITING

Bordeaux, France

Conditions

Explore the condition pages connected to this study.

PTEN GENE MUTATION